The McKesson Drugs of Abuse Test is a comprehensive preliminary screening solution designed to safeguard workplaces, schools, and organizations from the risks of substance abuse. With CLIA-Waved urine drug screen status, this convenient test empowers users with the ability to detect up to 14 analytes and 3 adulterants with unparalleled accuracy. The test panel includes amphetamine, barbiturates, benzodiazepines, buprenorphine, cocaine, methamphetamine, ecstasy, opiates, methadone, oxycodone, PCP, propoxyphene, tricyclic antidepressants, and marijuana. Furthermore, the test employs low-level cut-offs for buprenorphine and opiates, enhancing precision in detecting these substances. The rapid results, available within 5 minutes, facilitate quick and efficient screening. Moreover, the built-in Specimen Validity Test (SVT) and the included Adulteration Color Comparison Chart Card ensure the integrity of the specimens and aid in detecting any attempts at adulteration. This affordable and easy-to-use test delivers accurate and reliable drug screening, empowering organizations to protect their members from the dangers of substance abuse.

• Visually readable results in 5 minutes: Delivers fast and convenient drug screening.
• Tests for up to 14 analytes with adulteration detection: Provides comprehensive screening.
• Low-level opiate cut-offs: Offers detailed detection of specific drugs.
• Built-in SVT and temperature gauge: Monitors specimen validity and tampering.
• Easy-to-use cup format: Minimizes user error and exposure. Individually pouched for hygiene.